Related Experiment Video
Updated: Jun 6, 2026
09:35
A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
The CDK4-pRB-E2F1 pathway : A new modulator of insulin secretion
Lluis Fajas1, Emilie Blanchet, Jean-Sébastien Annicotte
1Institut de Recherche en Cancérologie de Montpellier, France. lluis.fajas@inserm.fr
Islets
|November 25, 2010
Summary
Cell cycle regulators, like E2F1, play a novel role in pancreatic beta-cell function. Understanding these factors offers new pathways for treating type 2 diabetes by modulating insulin secretion.
Area of Science:
- Endocrinology
- Cell Biology
- Metabolic Diseases
Background:
- Pancreatic beta-cells regulate blood glucose by secreting insulin.
- Type 2 diabetes (T2D) involves impaired insulin secretion due to chronic hyperglycemia.
- Cell cycle regulators are highly expressed in non-proliferating beta-cells, suggesting potential roles beyond proliferation.
Purpose of the Study:
- To investigate the role of cell cycle regulators, specifically E2F1, in pancreatic beta-cell function.
- To explore the potential of these regulators in modulating insulin secretion for diabetes treatment.
Main Methods:
- Analysis of cell cycle regulator expression in pancreatic beta-cells.
- Investigating the function of E2F1 in beta-cell proliferation and insulin secretion.
- Utilizing models of hyperglycemia and type 2 diabetes.
Main Results:
- E2F1 is involved in pancreatic beta-cell proliferation.
- Cell cycle regulators demonstrate a direct role in controlling insulin secretion.
- Data suggests these factors are key modulators of beta-cell function.
Conclusions:
- Cell cycle regulators, including E2F1, have a previously unrecognized function in regulating insulin secretion.
- These findings open new therapeutic avenues for managing type 2 diabetes by targeting beta-cell function.
More Related Videos
12:32High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
Published on: January 23, 2018
06:33Optimized Protocol for Generating Functional Pancreatic Insulin-secreting Cells from Human Pluripotent Stem Cells
Published on: February 2, 2024
Related Concept Videos
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:58Cell Specific Gene Expression
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...